These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11466867)

  • 21. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 23. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
    Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.
    Metlay JP; Fishman NO; Joffe M; Edelstein PH
    Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal vaccination: yes or no.
    Sharda KB
    Indian Pediatr; 2008 Jun; 45(6):519. PubMed ID: 18599950
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fulminating pneumococcal septicemia in a 2 year old child with sickle cell anemia].
    Visser M; Hogeman PH; van Vught AJ; Révész T; Wolfs TF
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):454-6. PubMed ID: 12666518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.
    Barzilay EJ; O'Brien KL; Kwok YS; Hoekstra RM; Zell ER; Reid R; Santosham M; Whitney CG; Feikin DR
    Vaccine; 2006 Feb; 24(7):904-13. PubMed ID: 16203059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Missing spleen: indication for pneumococcal vaccination].
    van Dijk GW; van Leeuwen HJ; van Gijn J; Hoepelman IM
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):425-8. PubMed ID: 12666509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunization promotion in adults and the elderly: needs, evidence, and operative proposals for health services].
    Piffer S; Moghadam PF
    Ann Ig; 2002; 14(3 Suppl 3):83-92. PubMed ID: 12389415
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dutch Health Council advice 'Vaccination against pneumococcal infections in elderly persons and immunocompromised adults'].
    Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):871-4. PubMed ID: 15152387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal vaccination and revaccination in the elderly population.
    Nichol KL
    J Infect Dis; 2010 Mar; 201(5):659-61. PubMed ID: 20113178
    [No Abstract]   [Full Text] [Related]  

  • 34. [Impact of invasive pneumococcal infection in children].
    Sáez-Llorens X
    An Esp Pediatr; 2002 Nov; 57(5):391-3. PubMed ID: 12467540
    [No Abstract]   [Full Text] [Related]  

  • 35. Influenza and pneumococcal disease: does vaccination make a difference?
    Clover RD
    Ethn Dis; 2002; 12(1):S2-36-8. PubMed ID: 11913637
    [No Abstract]   [Full Text] [Related]  

  • 36. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 38. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM; Geelen SP; Sanders EA; Wolfs TF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.